Sodium Sulfide 1% Gel Safety Supported By New Clinical Data - Schering
This article was originally published in The Tan Sheet
Executive Summary
The safety of sodium sulfide gel for the relief of pain associated with ingrown toenails is exhibited by the results of a clinical study conducted by Schering-Plough, the company tells FDA in an Oct. 13 citizen petition. Previous agency concerns regarding the ingredient's safety should be addressed by the findings, the petition says.